Plain-English translation of NCT06350032 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing treprostinil sodium, a medication that helps relax blood vessels in the lungs, in children under 18 who have severe pulmonary arterial hypertension (a condition where blood pressure in the lung arteries becomes dangerously high). The researchers want to make sure this new version of the medication—made without preservatives—is safe and works well for children.
While this medication has been shown to work for children with this serious condition, the researchers removed a preservative from it to make it safer for ongoing use. This trial is needed to confirm that the new formulation without the preservative is still safe and effective.
You likely qualify if…
You likely don't qualify if…
You would receive treprostinil as either an under-the-skin injection or intravenous infusion, with your dosage adjusted by the study doctor based on what your body needs. The trial will monitor you for safety and any side effects from the new medication formulation. Your participation involves regular check-ins and blood tests to make sure the treatment is working and that you're doing well.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Austria
France
Hungary
Slovakia
Spain